CARDINAL HEALTH INC News
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
see moreCARDINAL HEALTH INC Market News
5d
Cardinal Health Extends CVS Pharmaceutical Distribution Partnership Through 2032
- Cardinal Health (CAH) has entered into a binding Letter of Intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032 — a strategic move in the integrated healthcare services space.
12d
Cardinal Health Reports Q4 FY2026 Earnings Beat, Raises FY2027 Guidance and Expands Buyback Authorization
Cardinal Health beat Q4 earnings forecasts, guided FY 2027 non‑GAAP EPS to $12.40–$12.60, and raised its share buyback authorization to $6.4 billion.
19d
Cardinal Health Increases Quarterly Dividend Amid Ongoing Home‑Care Expansion
Cardinal Health (NYSE: CAH) approved a new quarterly dividend this week, reinforcing its shareholder return strategy as it advances its at‑home care growth.
26d
Cardinal Health Advances Tech-Enabled Strategy with $700 Million FY2027 Investment Push
Cardinal Health is accelerating its transformation into a tech-driven healthcare platform, earmarking $700 million for automation and analytics in FY2027.
09 Sep at 06:03
Cardinal Health Expands At‑Home Care Footprint with $360 Million Acquisitions
Cardinal Health has agreed to acquire AdaptHealth’s diabetes unit and Strive Medical for $360M in cash, bolstering its at‑Home Solutions and integrated care strategy.
02 Sep at 06:04
Cardinal Health Boosts Investor Appeal with $5 Billion Buyback Authorization Alongside Strong Q4 Results
Cardinal Health (CAH) delivered a 70 % surge in Q4 GAAP EPS to $1.70, raised its fiscal 2027 outlook above long‑term targets, and unveiled a $5 billion stock repurchase plan.
26 Aug at 06:04
Cardinal Health Reports Strong Q4 Fiscal 2026 Results and Boosts FY27 Guidance After Home Care Acquisitions
Cardinal Health (NYSE: CAH) delivered a 6% Q4 revenue increase to $63.7B and 70% GAAP EPS growth, citing acquisitions of AdaptHealth Diabetes Health and Strive Medical, raising FY27 non‑GAAP EPS guidance by 13‑15%.